UB Paderborn / Katalog / Suche / in CDI

1 – 19 von 19

Sortiert nach

Proof-of-concept study to evaluate the safety and efficacy of saroglitazar in patients with primary biliary cholangitis

Journal of hepatology, 2022-01, Vol.76 (1), p.75-85

2022

Volltextzugriff (PDF)

Features of Metabolic Syndrome as a Predictor of NAFLD Activity Score and Histological Patterns of NAFLD: 1012

The American journal of gastroenterology, 2017-10, Vol.112, p.S565-S566

2017

Volltextzugriff (PDF)

Baseline AST, Hypertriglyceridemia and Female Gender are Independent Predictors of Progression to Nonalcoholic Steatohepatitis in Patients with Nonalcoholic Fatty Liver Disease: 2773

The American journal of gastroenterology, 2017-10, Vol.112, p.S1499

2017

Volltextzugriff (PDF)

Co-morbidities Help Predict NAFLD Progression: 2772

The American journal of gastroenterology, 2017-10, Vol.112, p.S1498-S1499

2017

Volltextzugriff (PDF)

Efficacy and Safety of Elafibranor in Primary Biliary Cholangitis

The New England journal of medicine, 2024-02, Vol.390 (9), p.795

2024

Volltextzugriff (PDF)

Posttransplant Outcome of Lean Compared With Obese Nonalcoholic Steatohepatitis in the United States: The Obesity Paradox

Liver transplantation, 2020-01, Vol.26 (1), p.68-79

2020

Volltextzugriff (PDF)

Tu1559 – Post-Transplant Outcome of Lean Compared to Obese Nonalcoholic Steatohepatitis in the United States: the Obesity Paradox

Gastroenterology (New York, N.Y. 1943), 2019-05, Vol.156 (6), p.S-1358-S-1358

2019

Volltextzugriff (PDF)

Lack of Clostridium difficile Infection in Patients Treated With Rifaximin for Hepatic Encephalopathy: A Retrospective Analysis

Journal of clinical gastroenterology, 2013-02, Vol.47 (2), p.188-192

2013

Volltextzugriff (PDF)

Durability of Rifaximin Response in Hepatic Encephalopathy

Journal of clinical gastroenterology, 2012-02, Vol.46 (2), p.168-171

2012

Volltextzugriff (PDF)

Adult Onset Urea Cycle Disorder in a Patient With Presumed Hepatic Encephalopathy

Journal of clinical gastroenterology, 2008-02, Vol.42 (2), p.213-214

2008

Volltextzugriff (PDF)

Rosiglitazone toxicity

Annals of internal medicine, 2000-10, Vol.133 (8), p.658

2000

Volltextzugriff (PDF)

Prevalence of hepatitis A virus antibodies in patients with cirrhosis

The American journal of gastroenterology, 2002-09, Vol.97 (9), p.S89-S89

2002

Volltextzugriff (PDF)

Complete ablation of bleeding stromal tumor of stomach with left gastric artery embolization

The American journal of gastroenterology, 2002-09, Vol.97 (9), p.S156-S156

2002

Volltextzugriff (PDF)

Safety, tolerability and efficacy of interferon alfa 2b and Ribavirin combination therapy in HCV patients with cirrhosis

Gastroenterology (New York, N.Y. 1943), 2003-04, Vol.124 (4), p.A383-A383

2003

Volltextzugriff (PDF)

Antibody persistence following administration of a hexavalent DTwP-IPV-HB-PRP∼T vaccine versus separate DTwP-HB-PRP∼T and IPV vaccines at 12–24 months of age and safety and immunogenicity of a booster dose of DTwP-IPV-HB-PRP∼T in healthy infants in India

Vaccine: X, 2022-08, Vol.11, p.100190-100190, Article 100190

2022

Volltextzugriff (PDF)

Safety and immunogenicity of a hexavalent DTwP-IPV-HB-PRP∼T vaccine versus separate DTwP-HB-PRP∼T and IPV vaccines in healthy infants in India

Vaccine: X, 2022-04, Vol.10, p.100137-100137, Article 100137

2022

Volltextzugriff (PDF)

Lot-to-lot consistency of a hexavalent DTwP-IPV-HB-PRP∼T vaccine and non-inferiority to separate DTwP-HB-PRP∼T and IPV antigen-matching vaccines at 6–8, 10–12, and 14–16 weeks of age co-administered with oral rotavirus vaccine in healthy infants in India: A multi-center, randomized, controlled study

Vaccine: X, 2022-12, Vol.12, p.100216-100216, Article 100216

2022

Volltextzugriff (PDF)

Effect of prophylactic or therapeutic administration of paracetamol on immune response to DTwP-HepB-Hib combination vaccine in Indian infants

Vaccine, 2017-05, Vol.35 (22), p.2999-3006

2017

Volltextzugriff (PDF)

Safety, immune lot-to-lot consistency and non-inferiority of a fully liquid pentavalent DTwp-HepB-Hib vaccine in healthy Indian toddlers and infants

Human vaccines & immunotherapeutics, 2016-04, Vol.12 (4), p.946-954

2016

Volltextzugriff (PDF)

1 – 19 von 19

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(19)
Mit Volltextzugriff
(12)

Publikationsform

Artikel
(19)

Sprache

Englisch
(19)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(12)
Science & Technology
(12)
Humans
(9)
Female
(6)
Immunology
(6)
Male
(6)
Gastroenterology & Hepatology
(5)
Middle Aged
(5)
Medicine, Research & Experimental
(4)
Research & Experimental Medicine
(4)
Treatment Outcome
(4)
Hexavalent
(3)
Immunogenicity
(3)
Patients
(3)
Regular Paper
(3)
Vaccine
(3)
Adult
(2)
Alkaline Phosphatase
(2)
Anti-Infective Agents - Adverse Effects
(2)
Anti-Infective Agents - Therapeutic Use
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Proof-of-concept study to evaluate the safety and efficacy of saroglitazar in patients with primary biliary cholangitis

Features of Metabolic Syndrome as a Predictor of NAFLD Activity Score and Histological Patterns of NAFLD: 1012

Baseline AST, Hypertriglyceridemia and Female Gender are Independent Predictors of Progression to Nonalcoholic Steatohepatitis in Patients with Nonalcoholic Fatty Liver Disease: 2773

Co-morbidities Help Predict NAFLD Progression: 2772

Efficacy and Safety of Elafibranor in Primary Biliary Cholangitis

Posttransplant Outcome of Lean Compared With Obese Nonalcoholic Steatohepatitis in the United States: The Obesity Paradox

Tu1559 – Post-Transplant Outcome of Lean Compared to Obese Nonalcoholic Steatohepatitis in the United States: the Obesity Paradox

Lack of Clostridium difficile Infection in Patients Treated With Rifaximin for Hepatic Encephalopathy: A Retrospective Analysis

Durability of Rifaximin Response in Hepatic Encephalopathy

Adult Onset Urea Cycle Disorder in a Patient With Presumed Hepatic Encephalopathy

Rosiglitazone toxicity

Prevalence of hepatitis A virus antibodies in patients with cirrhosis

Complete ablation of bleeding stromal tumor of stomach with left gastric artery embolization

Safety, tolerability and efficacy of interferon alfa 2b and Ribavirin combination therapy in HCV patients with cirrhosis

Antibody persistence following administration of a hexavalent DTwP-IPV-HB-PRP∼T vaccine versus separate DTwP-HB-PRP∼T and IPV vaccines at 12–24 months of age and safety and immunogenicity of a booster dose of DTwP-IPV-HB-PRP∼T in healthy infants in India

Safety and immunogenicity of a hexavalent DTwP-IPV-HB-PRP∼T vaccine versus separate DTwP-HB-PRP∼T and IPV vaccines in healthy infants in India

Effect of prophylactic or therapeutic administration of paracetamol on immune response to DTwP-HepB-Hib combination vaccine in Indian infants

Safety, immune lot-to-lot consistency and non-inferiority of a fully liquid pentavalent DTwp-HepB-Hib vaccine in healthy Indian toddlers and infants

Suchergebnisse filtern